Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

BioAtla (BCAB) Invested Capital (2020 - 2025)

BioAtla (BCAB) has disclosed Invested Capital for 6 consecutive years, with $36.2 million as the latest value for Q4 2025.

  • For Q4 2025, Invested Capital rose 153.69% year-over-year to $36.2 million; the TTM value through Dec 2025 reached $36.2 million, up 153.69%, while the annual FY2025 figure was $36.2 million, 153.69% up from the prior year.
  • Invested Capital hit $36.2 million in Q4 2025 for BioAtla, up from -$31.2 million in the prior quarter.
  • Across five years, Invested Capital topped out at $230.7 million in Q3 2021 and bottomed at -$31.2 million in Q3 2025.
  • Average Invested Capital over 5 years is $102.3 million, with a median of $109.6 million recorded in 2023.
  • Year-over-year, Invested Capital surged 440.04% in 2021 and then crashed 236.0% in 2025.
  • BioAtla's Invested Capital stood at $210.8 million in 2021, then fell by 14.46% to $180.3 million in 2022, then tumbled by 60.81% to $70.7 million in 2023, then crashed by 79.82% to $14.3 million in 2024, then surged by 153.69% to $36.2 million in 2025.
  • According to Business Quant data, Invested Capital over the past three periods came in at $36.2 million, -$31.2 million, and -$16.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.